A1 Refereed original research article in a scientific journal
Beyond traditional medicine: Erythrophyleum suaveolens (Guill. & Perr.) Brenan shows promising antidiabetic activity in experimentally induced type II diabetes; 
Authors: Ojo, Oluwafemi Adeleke; Nwafor-Ezeh, Pearl Ifunanya; Ojo, Adebola Busola; Rotimi, Damilare Emmanuel; Ogunlakin, Akingbolabo Daniel; Akanbi, Clinton Ayodeji; Adeyemi, Peter Tolulope; Molehin, Olorunfemi Raphael
Publisher: Elsevier BV
Publication year: 2026
Journal: Kuwait Journal of Science
Article number: 100594
Volume: 53
Issue: 3
ISSN: 2307-4108
eISSN: 2307-4116
DOI: https://doi.org/10.1016/j.kjs.2026.100594
Publication's open availability at the time of reporting: Open Access
Publication channel's open availability : Open Access publication channel
Web address : https://doi.org/10.1016/j.kjs.2026.100594
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/523244492
Self-archived copy's licence: CC BY
Self-archived copy's version: Publisher`s PDF
This study aimed to investigate the antidiabetic activity of the methanolic extract of Erythrophyleum suaveolens stem bark (MEESS) in fructose-fed streptozotocin-induced diabetic Wistar rats. Diabetes was induced in rats by administering 10% fructose for two weeks, followed by an intraperitoneal (i.p.) injection of a low dose (40 mg/kg) of streptozotocin (STZ) to induce type 2 diabetes (T2D). The groups of experimental rats were categorized as follows: control, diabetic-control, diabetic metformin (100 mg/kg), diabetes + MEESS (150 mg/kg), and diabetes + MEESS (300 mg/kg). MEESS was administered to the two diabetic groups at doses of 150 and 300 mg/kg body weight. Following the conclusion of the experiment, blood samples (for serum collection) and liver tissues were collected for biochemical analysis. MEESS significantly (p < 0.05) attenuated STZ-induced elevations in blood glucose, alanine transaminase (ALT), aspartate transaminase (AST), triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL), very-low density lipoprotein (VLDL), and malondialdehyde (MDA) levels and restored the levels of superoxide dismutase (SOD), catalase, reduced glutathione (GSH), and high-density lipoprotein (HDL), which were previously depleted by STZ. In diabetic rats, MEESS treatment led to increased hexokinase activity and decreased G6Pase activity. Additionally, MEESS upregulated the mRNA expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2), NAD(P)H:quinone oxidoreductase-1 (NQO1), and peroxisome proliferator-activated receptor gamma (PPAR-γ = while downregulating kelch-like ECH-associated protein 1 (Keap1), protein tyrosine phosphatase 1B (PTP1B), and caspase-3 mRNA expression in the liver. MEESS regulates glucose homeostasis in diabetic rats while preventing redox imbalance.
Keywords:
Medicinal plants
Downloadable publication This is an electronic reprint of the original article. |  |
Funding information in the publication:
None received.
